← Evidence map

SynthesisNeuropsychopharmacology reports2024

Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real-world data.

Yoshiteru Takekita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37926930